Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-25-291392

Director sold 15,000 shares at $11.03 ($165,495)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Gould Robert J Director 2025-11-19 Sale −15,000 $11.03 $165,495 484,864 D
Open-market sales · 15,000 sh · avg $11.03 · $165,495
Loading xslF345X05/ownership.xml…